SOLVENTUM CORP (SOLV) Fundamental Analysis & Valuation

NYSE:SOLV • US83444M1018

Current stock price

68.97 USD
-1.07 (-1.53%)
At close:
68.97 USD
0 (0%)
After Hours:

This SOLV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. SOLV Profitability Analysis

1.1 Basic Checks

  • In the past year SOLV was profitable.
  • SOLV had a positive operating cash flow in the past year.
  • In the past 5 years SOLV has always been profitable.
  • In the past 5 years SOLV always reported a positive cash flow from operatings.
SOLV Yearly Net Income VS EBIT VS OCF VS FCFSOLV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

1.2 Ratios

  • SOLV has a Return On Assets of 10.89%. This is amongst the best in the industry. SOLV outperforms 91.98% of its industry peers.
  • Looking at the Return On Equity, with a value of 30.82%, SOLV belongs to the top of the industry, outperforming 97.33% of the companies in the same industry.
  • SOLV has a better Return On Invested Capital (5.40%) than 75.94% of its industry peers.
  • SOLV had an Average Return On Invested Capital over the past 3 years of 8.39%. This is in line with the industry average of 9.12%.
Industry RankSector Rank
ROA 10.89%
ROE 30.82%
ROIC 5.4%
ROA(3y)7.95%
ROA(5y)8.82%
ROE(3y)19.51%
ROE(5y)16.42%
ROIC(3y)8.39%
ROIC(5y)9.89%
SOLV Yearly ROA, ROE, ROICSOLV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • The Profit Margin of SOLV (18.69%) is better than 94.12% of its industry peers.
  • In the last couple of years the Profit Margin of SOLV has grown nicely.
  • SOLV's Operating Margin of 8.53% is fine compared to the rest of the industry. SOLV outperforms 77.01% of its industry peers.
  • SOLV's Operating Margin has declined in the last couple of years.
  • SOLV has a Gross Margin of 53.57%. This is comparable to the rest of the industry: SOLV outperforms 51.87% of its industry peers.
  • In the last couple of years the Gross Margin of SOLV has declined.
Industry RankSector Rank
OM 8.53%
PM (TTM) 18.69%
GM 53.57%
OM growth 3Y-25.46%
OM growth 5YN/A
PM growth 3Y4.2%
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5YN/A
SOLV Yearly Profit, Operating, Gross MarginsSOLV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. SOLV Health Analysis

2.1 Basic Checks

  • SOLV has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, SOLV has more shares outstanding
  • The debt/assets ratio for SOLV has been reduced compared to a year ago.
SOLV Yearly Shares OutstandingSOLV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 50M 100M 150M
SOLV Yearly Total Debt VS Total AssetsSOLV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 5B 10B

2.2 Solvency

  • SOLV has an Altman-Z score of 1.76. This is a bad value and indicates that SOLV is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.76, SOLV perfoms like the industry average, outperforming 54.01% of the companies in the same industry.
  • A Debt/Equity ratio of 1.00 indicates that SOLV is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 1.00, SOLV is not doing good in the industry: 77.01% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 1.76
ROIC/WACC0.69
WACC7.79%
SOLV Yearly LT Debt VS Equity VS FCFSOLV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • SOLV has a Current Ratio of 1.23. This is a normal value and indicates that SOLV is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of SOLV (1.23) is worse than 86.63% of its industry peers.
  • SOLV has a Quick Ratio of 1.23. This is a bad value and indicates that SOLV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SOLV has a worse Quick ratio (0.89) than 86.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.89
SOLV Yearly Current Assets VS Current LiabilitesSOLV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SOLV Growth Analysis

3.1 Past

  • SOLV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.82%.
  • Measured over the past 5 years, SOLV shows a small growth in Earnings Per Share. The EPS has been growing by 4.46% on average per year.
  • Looking at the last year, SOLV shows a small growth in Revenue. The Revenue has grown by 0.86% in the last year.
  • SOLV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.79% yearly.
EPS 1Y (TTM)-8.82%
EPS 3Y4.46%
EPS 5YN/A
EPS Q2Q%11.35%
Revenue 1Y (TTM)0.86%
Revenue growth 3Y0.79%
Revenue growth 5YN/A
Sales Q2Q%-3.66%

3.2 Future

  • Based on estimates for the next years, SOLV will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.89% on average per year.
  • The Revenue is expected to grow by 0.77% on average over the next years.
EPS Next Y7.95%
EPS Next 2Y8.36%
EPS Next 3Y8.89%
EPS Next 5YN/A
Revenue Next Year-1.18%
Revenue Next 2Y1.03%
Revenue Next 3Y2.01%
Revenue Next 5Y0.77%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SOLV Yearly Revenue VS EstimatesSOLV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
SOLV Yearly EPS VS EstimatesSOLV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. SOLV Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 11.31, the valuation of SOLV can be described as very reasonable.
  • SOLV's Price/Earnings ratio is rather cheap when compared to the industry. SOLV is cheaper than 91.44% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.66, SOLV is valued rather cheaply.
  • The Price/Forward Earnings ratio is 10.47, which indicates a very decent valuation of SOLV.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SOLV indicates a rather cheap valuation: SOLV is cheaper than 94.65% of the companies listed in the same industry.
  • SOLV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.00.
Industry RankSector Rank
PE 11.31
Fwd PE 10.47
SOLV Price Earnings VS Forward Price EarningsSOLV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • SOLV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. SOLV is cheaper than 83.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.44
SOLV Per share dataSOLV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of SOLV may justify a higher PE ratio.
PEG (NY)1.42
PEG (5Y)N/A
EPS Next 2Y8.36%
EPS Next 3Y8.89%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SOLV Dividend Analysis

5.1 Amount

  • No dividends for SOLV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SOLV Fundamentals: All Metrics, Ratios and Statistics

SOLVENTUM CORP

NYSE:SOLV (4/21/2026, 8:13:14 PM)

After market: 68.97 0 (0%)

68.97

-1.07 (-1.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-05
Inst Owners73.51%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner Change0.41%
Market Cap11.96B
Revenue(TTM)8.32B
Net Income(TTM)1.56B
Analysts73.33
Price Target87.95 (27.52%)
Short Float %3.65%
Short Ratio4.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.79%
Min EPS beat(2)2.66%
Max EPS beat(2)2.92%
EPS beat(4)4
Avg EPS beat(4)7.06%
Min EPS beat(4)2.66%
Max EPS beat(4)15.09%
EPS beat(8)8
Avg EPS beat(8)8.33%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.02%
Min Revenue beat(2)-0.15%
Max Revenue beat(2)0.19%
Revenue beat(4)2
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-0.15%
Max Revenue beat(4)0.68%
Revenue beat(8)2
Avg Revenue beat(8)-0.41%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.52%
PT rev (3m)-2.74%
EPS NQ rev (1m)0.22%
EPS NQ rev (3m)-8.59%
EPS NY rev (1m)0.25%
EPS NY rev (3m)1.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.96%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)2.42%
Valuation
Industry RankSector Rank
PE 11.31
Fwd PE 10.47
P/S 1.44
P/FCF N/A
P/OCF 32.41
P/B 2.37
P/tB N/A
EV/EBITDA 13.44
EPS(TTM)6.1
EY8.84%
EPS(NY)6.58
Fwd EY9.55%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)2.13
OCFY3.09%
SpS48.01
BVpS29.12
TBVpS-18.72
PEG (NY)1.42
PEG (5Y)N/A
Graham Number63.2152 (-8.34%)
Profitability
Industry RankSector Rank
ROA 10.89%
ROE 30.82%
ROCE 6.36%
ROIC 5.4%
ROICexc 5.87%
ROICexgc 30.39%
OM 8.53%
PM (TTM) 18.69%
GM 53.57%
FCFM N/A
ROA(3y)7.95%
ROA(5y)8.82%
ROE(3y)19.51%
ROE(5y)16.42%
ROIC(3y)8.39%
ROIC(5y)9.89%
ROICexc(3y)8.79%
ROICexc(5y)10.16%
ROICexgc(3y)43.79%
ROICexgc(5y)51.79%
ROCE(3y)9.88%
ROCE(5y)11.65%
ROICexgc growth 3Y-18.46%
ROICexgc growth 5YN/A
ROICexc growth 3Y-20.41%
ROICexc growth 5YN/A
OM growth 3Y-25.46%
OM growth 5YN/A
PM growth 3Y4.2%
PM growth 5YN/A
GM growth 3Y-2.47%
GM growth 5YN/A
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA 4.2
Cap/Depr 77.51%
Cap/Sales 4.55%
Interest Coverage 1.61
Cash Conversion 30.78%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.89
Altman-Z 1.76
F-Score6
WACC7.79%
ROIC/WACC0.69
Cap/Depr(3y)65.89%
Cap/Depr(5y)57.5%
Cap/Sales(3y)4.23%
Cap/Sales(5y)3.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.82%
EPS 3Y4.46%
EPS 5YN/A
EPS Q2Q%11.35%
EPS Next Y7.95%
EPS Next 2Y8.36%
EPS Next 3Y8.89%
EPS Next 5YN/A
Revenue 1Y (TTM)0.86%
Revenue growth 3Y0.79%
Revenue growth 5YN/A
Sales Q2Q%-3.66%
Revenue Next Year-1.18%
Revenue Next 2Y1.03%
Revenue Next 3Y2.01%
Revenue Next 5Y0.77%
EBIT growth 1Y-31.93%
EBIT growth 3Y-24.87%
EBIT growth 5YN/A
EBIT Next Year19.67%
EBIT Next 3Y10.8%
EBIT Next 5YN/A
FCF growth 1Y-101.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.86%
OCF growth 3Y-39.65%
OCF growth 5YN/A

SOLVENTUM CORP / SOLV Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SOLVENTUM CORP?

ChartMill assigns a fundamental rating of 4 / 10 to SOLV.


What is the valuation status of SOLVENTUM CORP (SOLV) stock?

ChartMill assigns a valuation rating of 6 / 10 to SOLVENTUM CORP (SOLV). This can be considered as Fairly Valued.


What is the profitability of SOLV stock?

SOLVENTUM CORP (SOLV) has a profitability rating of 7 / 10.


What is the financial health of SOLVENTUM CORP (SOLV) stock?

The financial health rating of SOLVENTUM CORP (SOLV) is 2 / 10.


What is the expected EPS growth for SOLVENTUM CORP (SOLV) stock?

The Earnings per Share (EPS) of SOLVENTUM CORP (SOLV) is expected to grow by 7.95% in the next year.